Literature DB >> 17354099

Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers.

N López-Holgado1, M Alberca, F Sánchez-Guijo, E Villarón, J Almeida, A Martín, A Armellini, C García, B Blanco, I Sánchez-Abarca, S Martín, J A Pérez-Simón, R García-Sanz, J F San Miguel, M C del Cañizo.   

Abstract

BACKGROUND: The aim of this study was to identify circulating endothelial progenitor cells (EPC) with colony-forming capacity and compare them with the monocytic-macrophage lineage.
METHODS: Forty-two healthy donors were analyzed. EPC were cultured with VEGF and b-FGF. Sequential studies were performed on days +7 (colonies) +21 and +35. Monocytic cells were cultured using the same conditions as EPC until day +21 or alternatively by adding IGF.
RESULTS: The number of EPC colonies was higher in BM than in mobilized or steady-state PB. Using EPC medium, monocytic cells formed cord-like structures but no colonies. However, colonies grew when IGF was added to the medium. By immunocytochemistry, colonies showed CD45, CD31 and lysozyme but no vWF. Colonies were CD4+, CD13+dim, CD14+, CD15++, CD16-/+dim, CD31+dim, CD33+dim, CD45+, CD105-/+dim, lysozyme+ and VE-cadherin+, and constantly negative for CD34, CD133 and KDR, when flow cytometry was used. The immunophenotype of pre-cultured and cultured monocytes was similar to that described for EPC. DISCUSSION: Our results suggest that the so-called 'EPC' obtained at 7 days of culture belong to the monocyte-macrophage lineage, as they share immunophenotypic and molecular features.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17354099     DOI: 10.1080/14653240601047726

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  7 in total

Review 1.  Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.

Authors:  Gian Paolo Fadini; Douglas Losordo; Stefanie Dimmeler
Journal:  Circ Res       Date:  2012-02-17       Impact factor: 17.367

Review 2.  Vascular stem cells in diabetic complications: evidence for a role in the pathogenesis and the therapeutic promise.

Authors:  Emily C Keats; Zia A Khan
Journal:  Cardiovasc Diabetol       Date:  2012-04-23       Impact factor: 9.951

3.  Unique responses of stem cell-derived vascular endothelial and mesenchymal cells to high levels of glucose.

Authors:  Emily Keats; Zia A Khan
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

4.  Improving the characterization of endothelial progenitor cell subsets by an optimized FACS protocol.

Authors:  Karin Huizer; Dana A M Mustafa; J Clarissa Spelt; Johan M Kros; Andrea Sacchetti
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

5.  Lysozyme and bilirubin bind to ACE and regulate its conformation and shedding.

Authors:  Sergei M Danilov; Heinrich Lünsdorf; Henry T Akinbi; Andrew B Nesterovitch; Yuliya Epshtein; Eleftheria Letsiou; Olga V Kryukova; Tobias Piegeler; Elena Z Golukhova; David E Schwartz; Randal O Dull; Richard D Minshall; Olga A Kost; Joe G N Garcia
Journal:  Sci Rep       Date:  2016-10-13       Impact factor: 4.379

Review 6.  Dysfunction and Therapeutic Potential of Endothelial Progenitor Cells in Diabetes Mellitus.

Authors:  Lidong Hu; Si-Cheng Dai; Xiaojun Luan; Jingsong Chen; Anthony Cannavicci
Journal:  J Clin Med Res       Date:  2018-09-10

7.  Circulating angiogenic cell dysfunction in patients with hereditary hemorrhagic telangiectasia.

Authors:  Liana Zucco; Qiuwang Zhang; Michael A Kuliszewski; Ivana Kandic; Marie E Faughnan; Duncan J Stewart; Michael J Kutryk
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.